SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-027915
Filing Date
2011-03-23
Accepted
2011-03-23 06:01:13
Documents
4
Period of Report
2011-03-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a59043e8vk.htm 8-K 21411
2 EX-10.1 a59043exv10w1.htm EX-10.1 179910
3 EX-99.1 a59043exv99w1.htm EX-99.1 2632
4 GRAPHIC a59043a5904300.gif GRAPHIC 5698
  Complete submission text file 0000950123-11-027915.txt   213440
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 11705144
SIC: 2834 Pharmaceutical Preparations